The drug "Buskopan". Instructions

The drug "Buskopan" has an antispasmodic effect aimed at the smooth muscles of the digestive tract, urogenital and bile excretory systems. The drug also lowers the secretion of digestive glands.

The drug "Buskopan". Instruction: indications

The drug is prescribed for spastic conditions of the biliary tract, gastrointestinal tract, urogenital tract (cholecystitis, renal, intestinal colic, pilorospazme and others). The medication is shown (as a component of complex therapy) for peptic ulcer in the duodenum and stomach in the acute stage. The drug is also used for algodismenorrhea, spastic dyskinesia in bile ducts.

The medicine "Buskopan". Instructions for use

The drug is prescribed for patients older than six years three times a day for one or two tablets inside or rectally suppositories (suppositories). The duration of the therapeutic course is determined by a specialist individually.

Tablets should be washed down with water in sufficient quantities. The candles are inserted into the anus anteriorly with a pointed end.

The drug "Buskopan". Instruction: side effect

Undesirable manifestations in the use of the drug are associated with its anticholinergic action. Patients may have dry mouth and skin, drowsiness, palpitations, probably difficulty urinating. Possible allergic reactions in the form of skin rashes, shortness of breath (in rare cases).

To the contraindications for taking the drug "Buskopan" the instruction refers to edema in the lungs, zakratougolnuyu glaucoma, myasthenia gravis, pronounced atherosclerosis in the vessels of the brain, megacolon (malformation of the large intestine), as well as hypersensitivity to the components of the drug.

The drug is administered with caution to patients with prostatic adenoma, with narrowing (stenosis) of the gatekeeper, obstruction of the intestine of a mechanical nature, tachysystole with fibrillation in the atria.

The expediency of prescribing the medicine "Buskopan" during pregnancy and lactation is determined by the doctor. At present, there is no evidence of a negative or safe effect of the drug on the fetus or on the newborn breast fed.

Cases of overdose with tablets in clinical practice are not described. Presumptive symptoms of the condition are manifested in the form of dry mouth, tachycardia, urinary retention, reddening of the skin, transient visual impairment, suppression of gastrointestinal motility. As a first aid, gastric lavage with activated carbon is used.

The drug "Buskopan" enhances the induced by beta-adrenomimetics tachycardia. The medication is able to enhance the anticholinergic effect of antihistamine group drugs, tricyclic antidepressants, amantadine, quinidine, and disopyramide.

Simultaneous use of antagonists of dopamine and the drug "Buskopan" weakens the effect of both drugs on the digestive tract.

The drug in tablet form and in the form of suppositories (rectal) is recommended to store at a temperature of not more than twenty-five degrees in a place inaccessible to children. Shelf life of the drug is five years, after which the drug should not be used.

On the use of the drug "Buskopan" in gynecology, the opinions of specialists are more positive. So, according to the results of clinical studies, the medicine with the suppression of muscle contractions provoked by acetylcholine was forty-four times more effective than the bioequivalent dosages of Drotaverina spasmolytics. These and other research results allow to classify the drug "Buscopan" as an effective antispasmodic of local effects, and also recommend its use as part of complex therapy for patients with symptoms of discomfort and spasmodic pain.